Published in

Springer, International Journal of Clinical Oncology, 8(25), p. 1523-1532, 2020

DOI: 10.1007/s10147-020-01691-0

Links

Tools

Export citation

Search in Google Scholar

Emerging RAS, BRAF, and EGFR mutations in cell-free DNA of metastatic colorectal patients are associated with both primary and secondary resistance to first-line anti-EGFR therapy

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO